Actively Recruiting
Exploratory Study of Ultrasound Nerve Ablation for Treating Essential Hypertension in Adults Aged 18 to 65
Led by Shenzhen Pulsecare Medical Technology Co., Ltd. · Updated on 2025-06-19
6
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to explore the safety and effectiveness of an ultrasonic nerve ablation system for treating patients with essential hypertension. The study will include adults aged 18 to 65 years who have essential hypertension and are taking multiple blood pressure medications. The trial is planned to be conducted at two research sites in China and will enroll a total of six participants. Participants will undergo treatment using the ultrasonic nerve ablation system. Before enrollment, they will have a renal artery CTA angiography to evaluate artery size and condition. After treatment, patients will be monitored regularly with clinical evaluations and blood pressure measurements at discharge, then at 1, 2, 3, and 6 months post-operation. Medication adjustments are recommended only when blood pressure reaches specific high or low thresholds. During the study, researchers will assess changes in daytime systolic blood pressure two months after treatment and monitor major adverse events within 30 days. Additional measurements include blood pressure changes over 24 hours, medication usage, complication rates, mortality, and device performance. Participants will be followed for six months post-operation with multiple clinical visits and assessments to monitor safety and treatment outcomes.
CONDITIONS
Brief Title
Safety and Efficacy of Modulated Ultrasound Renal Denervation for HTN(FIM)
Research Team
J
Jingfeng J wang, Postdoctoral fellow
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here